Nandrolone in protein powder

NandroMax is the premier 19-Nor-Andro prohormone in the industry. Featuring 60 mg of 19-Nor-Andro at 90 capsules with Cyclosome™ Delivery Technology. Spartans, as always, we’ve brought the apex of quality and efficacious dosing. Prepare for unparalleled gains.

NandroMax aids:

-Lean Muscle Mass Gains
-Increased Strength Gains
-6:1 Androgenic Ration
-Joint Support/Lubrication
-Elevated Nitrogen Retention

NandroMax l 19-Nor-Andro FAQ’s

19-Nor-Andro is a naturally occurring metabolite of DHEA. 19-Nor-Andro undergoes a three step conversion within the body from 19-Nor-DHEA to 19-nor-dione to 19-nortestosterone, commonly known as the treasured nandrolone. 19-Nor-Andro lacks the carbon atom at the 19th position, resulting in it being mildly estrogenic with low estrogenic side effects.

CYCLOSOME DELIVERY TECHNOLOGY

Cyclosome Delivery Technology is the premier pharmaceutical grade delivery technology for prohormones – better than the very common Liposomal by eons – and that’s without a doubt. Cyclosome Technology is the reason prohormone compounds today are feasible.

Cyclosome increases the bioavailability and effectiveness of prohormone compounds by undergoing cyclodextrin prior to lipid encapsulation. Cyclosome™ Delivery boasts a monstrous increase of >90% increase in bioavailability – meaning higher yield of absorption and increased gains!

Cyclosome Delivery is the first 100% pharmaceutical grade delivery system to combine both cyclodextrins and liposomes in supplements. Many of our “competitors” use Liposomal Technology, however all the data shows that it is subpar in comparison to Cyclosome - and a whole lot more expensive to use. At Sparta, we simply produce the best. 

SIDE EFFECTS:
It should be noted that in theory if one was to consistently suppress your natural estrogen levels for a long period of time, this would negatively impact your health, including your cholesterol. Due to the ability of Letrozole- to inhibit estrogen so much, this should definitely be a concern to most users. However the research that has focused on the relationship between use of letrozole and cholesterol levels is rather inconsistent in it's findings. Many studies have concluded that the compound is detrimental to both a user's HDL and LDL cholesterol levels, while other research has found no link. Obviously individuals are best served to monitor their cholesterol while using any compound via blood tests however barring that, letrozole should simply not be run for extended periods of time if at all possible. Doing so could cause serious medical complications.
Along with the issues related to blood lipids is the fact that many users complain that their libido is dramatically reduced when using the compound. This is related to the fact that estrogen is partly responsible for the regulation of an individual's sex drive. Since Letrozole- is so potent it can often drive estrogen levels too low and this inhibits a user's libido. To avoid this users can lower dosages, but some anecdotally report that even extremely low doses of the drug can cause problems. If this is the case a less potent compound such as exemestane or anastrozole may be a more appropriate option.

Many athletes, ball players, fighters, and any athlete who could benefit from the therapeutic relief often supplement with Deca Durabolin. Such individuals commonly have no desire to build any new lean muscle mass, but the relief alone is invaluable. Further, such relief can be obtained by a very low dose. A slightly higher dose will provide relief, greatly enhance overall recovery, and enhance muscular endurance. When it comes to performance enhancement, most athletes will find this steroid is hard to beat. More importantly, the relief effects of Deca Durabolin are not masking or false; this anabolic steroid shares nothing in common with over the counter painkillers or prescription painkillers like opiates. Such painkillers only mask the pain, whereas Deca Durabolin can actually heal the body.

(1) Gold J, Batterham MJ, Rekers H, Harms MK, Geurts TB, Helmyr PM, Silva de Mendonça J, Falleiros Carvalho LH, Panos G, Pinchera A, et al.
Effects of nandrolone decanoate compared with placebo or testosterone on HIV-associated wasting.
HIV Med. 2006 Apr; 7(3):146-55.
(2) Johansen KL, Mulligan K, Schambelan M. Anabolic effects of nandrolone decanoate in patients receiving dialysis: a randomized controlled trial.
JAMA. 1999 Apr 14; 281(14):1275-81.
(3) Frisoli A Jr., Chaves PH, Pinheiro MM, Szejnfeld VL. The effect of nandrolone decanoate on bone mineral density, muscle mass, and hemoglobin levels in elderly women with osteoporosis: a double-blind, randomized, placebo-controlled clinical trial. J. Gerontol A Biol Sci Med Sci 2005 May;60(5):648-53.
(4) Chawla B, Iqbal FM, Chawla MS. Nandrolone decanoate for the treatment of erythropoietin refractory anemia: a case series.
Compr Ther 2009 Fall-Winter;35(3-4):199-203.
(5) Hackenberg R, Schulz KD. Androgen receptor mediated growth control of breast cancer and endometrial cancer modulated by antiandrogen- and androgen-like steroids.
J Steroid Biochem Mol Biol. 1996 Jan; 56(1-6 Spec No):113-7.
(6) Velema MS, Kwa BH, de Ronde W. Should androgenic anabolic steroids be considered in the treatment regime of selected chronic obstructive pulmonary disease patients?
Curr Opin Pulm Med 2012 Mar;18(2):118-24.
(7) Labib M, Haddon A. The adverse effects of anabolic steroids on serum lipids. Ann Clin Biochem. 1996 May;33 ( Pt 3):263-4
(8) Santamarina RD, Besocke AG, Romano LM, Ioli PL, Gonorazky SE. Ischemic stroke related to anabolic abuse. Clin Neuropharmacol. 2008; 31(2): 80-5
(9) Lane HA, Grace F, Smith JC, Morris K, Cockcroft J, Scanlon MF, Davies JS. Impaired vasoreactivity in bodybuilders using androgenic anabolic steroids. Eur J Clin Invest. 2006 Jul;36(7):483-8.
(10) Hartgens F, Kuipers H. Effects of androgenic-anabolic steroids in athletes. Sports Med. 2004;34(8):513-54.
(11) Brower KJ, Eliopulos GA, Blow FC, Catlin DH, Beresford TP. Evidence for physical and psychological dependence on anabolic androgenic steroids in eight weight lifters. Am J Psychiatry. 1990 Apr;147(4):510-2.
(12) Da Justa Neves DB, Marcheti RG, Caldas ED. Incidence of anabolic steroid counterfeiting in Brazil. Forensic Sci Int 2013; 228(1-3): e81-3
(13) Topo E, Soricelli A, D’Aniello A, Ronsini S, D’Aniello G. The role and molecular mechanism of D-aspartic acid in the release and synthesis of LH and testosterone in humans and rats. Reprod Biol Endocrinol. 2009 Oct 27;7:120

Nandrolone in protein powder

nandrolone in protein powder

(1) Gold J, Batterham MJ, Rekers H, Harms MK, Geurts TB, Helmyr PM, Silva de Mendonça J, Falleiros Carvalho LH, Panos G, Pinchera A, et al.
Effects of nandrolone decanoate compared with placebo or testosterone on HIV-associated wasting.
HIV Med. 2006 Apr; 7(3):146-55.
(2) Johansen KL, Mulligan K, Schambelan M. Anabolic effects of nandrolone decanoate in patients receiving dialysis: a randomized controlled trial.
JAMA. 1999 Apr 14; 281(14):1275-81.
(3) Frisoli A Jr., Chaves PH, Pinheiro MM, Szejnfeld VL. The effect of nandrolone decanoate on bone mineral density, muscle mass, and hemoglobin levels in elderly women with osteoporosis: a double-blind, randomized, placebo-controlled clinical trial. J. Gerontol A Biol Sci Med Sci 2005 May;60(5):648-53.
(4) Chawla B, Iqbal FM, Chawla MS. Nandrolone decanoate for the treatment of erythropoietin refractory anemia: a case series.
Compr Ther 2009 Fall-Winter;35(3-4):199-203.
(5) Hackenberg R, Schulz KD. Androgen receptor mediated growth control of breast cancer and endometrial cancer modulated by antiandrogen- and androgen-like steroids.
J Steroid Biochem Mol Biol. 1996 Jan; 56(1-6 Spec No):113-7.
(6) Velema MS, Kwa BH, de Ronde W. Should androgenic anabolic steroids be considered in the treatment regime of selected chronic obstructive pulmonary disease patients?
Curr Opin Pulm Med 2012 Mar;18(2):118-24.
(7) Labib M, Haddon A. The adverse effects of anabolic steroids on serum lipids. Ann Clin Biochem. 1996 May;33 ( Pt 3):263-4
(8) Santamarina RD, Besocke AG, Romano LM, Ioli PL, Gonorazky SE. Ischemic stroke related to anabolic abuse. Clin Neuropharmacol. 2008; 31(2): 80-5
(9) Lane HA, Grace F, Smith JC, Morris K, Cockcroft J, Scanlon MF, Davies JS. Impaired vasoreactivity in bodybuilders using androgenic anabolic steroids. Eur J Clin Invest. 2006 Jul;36(7):483-8.
(10) Hartgens F, Kuipers H. Effects of androgenic-anabolic steroids in athletes. Sports Med. 2004;34(8):513-54.
(11) Brower KJ, Eliopulos GA, Blow FC, Catlin DH, Beresford TP. Evidence for physical and psychological dependence on anabolic androgenic steroids in eight weight lifters. Am J Psychiatry. 1990 Apr;147(4):510-2.
(12) Da Justa Neves DB, Marcheti RG, Caldas ED. Incidence of anabolic steroid counterfeiting in Brazil. Forensic Sci Int 2013; 228(1-3): e81-3
(13) Topo E, Soricelli A, D’Aniello A, Ronsini S, D’Aniello G. The role and molecular mechanism of D-aspartic acid in the release and synthesis of LH and testosterone in humans and rats. Reprod Biol Endocrinol. 2009 Oct 27;7:120

Media:

nandrolone in protein powdernandrolone in protein powdernandrolone in protein powdernandrolone in protein powdernandrolone in protein powder

http://buy-steroids.org